China SXT Pharmaceuticals (SXTC) Notes Payables: 2018-2025
Historic Notes Payables for China SXT Pharmaceuticals (SXTC) over the last 7 years, with Mar 2025 value amounting to $702,184.
- China SXT Pharmaceuticals' Notes Payables rose 17.93% to $976,367 in Q3 2025 from the same period last year, while for Sep 2025 it was $976,367, marking a year-over-year increase of 17.93%. This contributed to the annual value of $702,184 for FY2025, which is 42.42% up from last year.
- As of FY2025, China SXT Pharmaceuticals' Notes Payables stood at $702,184, which was up 42.42% from $493,054 recorded in FY2024.
- China SXT Pharmaceuticals' Notes Payables' 5-year high stood at $702,184 during FY2025, with a 5-year trough of $37,122 in FY2021.
- Its 3-year average for Notes Payables is $454,230, with a median of $493,054 in 2024.
- As far as peak fluctuations go, China SXT Pharmaceuticals' Notes Payables decreased by 15.44% in 2021, and later skyrocketed by 194.44% in 2024.
- Over the past 4 years, China SXT Pharmaceuticals' Notes Payables (MRY) stood at $37,122 in 2021, then surged by 351.09% to $167,453 in 2023, then skyrocketed by 194.44% to $493,054 in 2024, then soared by 42.42% to $702,184 in 2025.
- Its Notes Payables was $702,184 in FY2025, compared to $493,054 in FY2024 and $167,453 in FY2023.